Recent advances in Clostridium difficile-associated disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19351643.
- Also identified by DOI 10.1136/gut.2007.128157.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The main purpose of this article is to review recent developments in the management of acute and recurrent Clostridium difficile-associated disease, with consideration of existing and new antibiotic and non-antibiotic agents for treatment. Details of the current developmental stage of new agents are provided and the role of surgery in the management of severe disease is discussed. Infection control measures considered comprise prudent use of antimicrobials, prevention of cross-infection and surveillance. Other topics that are covered include the recent emergence of an epidemic hypervirulent strain, pathogenesis, clinical presentation and approaches to rapid diagnosis and assessment of the colonic disease.
Medical subject headings
- Anti-Bacterial Agents
- Clostridioides difficile
- Enterocolitis, Pseudomembranous